Companies are fighting for strong relationships with key opinion leaders—and Genentech is winning, hands down.
Genentech had previously been number one by a very wide margin. This year, that margin started to narrow. Novartis is now a much closer second
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial